wegovy glp 1 FDA approves pill and changes everything about GLP-1 drugs GLP-1 weight loss drugs may

Using a saliva specimen, Genetic Insights analyzes 36 genes to identify potential risk of nearly two dozen inheritable conditions, including breast and colon cancer

It combines cagrilintide, which mimics the bodys natural appetite-controlling hormone amylin, and semaglutide, a GLP-1 agonist

When you eat, the injection helps your body release insulin at the right time, controls your blood sugar better, and reduces cravings especially for sugary or fatty foods

It strengthens your immunity by protecting your cells from side effects of oxidative damage

The drugmaker said earlier this week that its CT-388 weight loss injection was entering a phase III trial the final stage before a company can seek regulatory approval marking the latest development in Roche's nascent but fast-growing pipeline of treatments for obesity and related conditions

But is it really effective, or is it just another hyped-up product